Compare NKSH & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NKSH | SMTI |
|---|---|---|
| Founded | 1891 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.1M | 186.9M |
| IPO Year | N/A | N/A |
| Metric | NKSH | SMTI |
|---|---|---|
| Price | $38.94 | $20.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $41.00 |
| AVG Volume (30 Days) | 16.1K | ★ 63.6K |
| Earning Date | 01-22-2026 | 03-24-2026 |
| Dividend Yield | ★ 3.88% | N/A |
| EPS Growth | ★ 101.13 | N/A |
| EPS | ★ 2.49 | N/A |
| Revenue | $55,579,000.00 | ★ $101,877,532.00 |
| Revenue This Year | N/A | $21.60 |
| Revenue Next Year | N/A | $16.70 |
| P/E Ratio | $15.65 | ★ N/A |
| Revenue Growth | 25.94 | ★ 30.52 |
| 52 Week Low | $23.75 | $18.90 |
| 52 Week High | $39.66 | $36.60 |
| Indicator | NKSH | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 81.08 | 38.81 |
| Support Level | $35.95 | $20.12 |
| Resistance Level | $38.91 | $22.43 |
| Average True Range (ATR) | 0.85 | 1.19 |
| MACD | 0.23 | -0.15 |
| Stochastic Oscillator | 95.08 | 12.47 |
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.